Cargando…

Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice

Heme oxygenase-1 (Hmox1) is a stress-inducible protein crucial in heme catabolism. The end products of its enzymatic activity possess anti-oxidative, anti-apoptotic and anti-inflammatory properties. Cardioprotective effects of Hmox1 were demonstrated in experimental models of myocardial infarction (...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomczyk, Mateusz, Kraszewska, Izabela, Szade, Krzysztof, Bukowska-Strakova, Karolina, Meloni, Marco, Jozkowicz, Alicja, Dulak, Jozef, Jazwa, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440541/
https://www.ncbi.nlm.nih.gov/pubmed/28534119
http://dx.doi.org/10.1007/s00395-017-0629-y
_version_ 1783238080742817792
author Tomczyk, Mateusz
Kraszewska, Izabela
Szade, Krzysztof
Bukowska-Strakova, Karolina
Meloni, Marco
Jozkowicz, Alicja
Dulak, Jozef
Jazwa, Agnieszka
author_facet Tomczyk, Mateusz
Kraszewska, Izabela
Szade, Krzysztof
Bukowska-Strakova, Karolina
Meloni, Marco
Jozkowicz, Alicja
Dulak, Jozef
Jazwa, Agnieszka
author_sort Tomczyk, Mateusz
collection PubMed
description Heme oxygenase-1 (Hmox1) is a stress-inducible protein crucial in heme catabolism. The end products of its enzymatic activity possess anti-oxidative, anti-apoptotic and anti-inflammatory properties. Cardioprotective effects of Hmox1 were demonstrated in experimental models of myocardial infarction (MI). Nevertheless, its importance in timely resolution of post-ischemic inflammation remains incompletely understood. The aim of this study was to determine the role of Hmox1 in the monocyte/macrophage-mediated cardiac remodeling in a mouse model of MI. Hmox1 knockout (Hmox1(−/−)) and wild-type (WT, Hmox1(+/+)) mice were subjected to a permanent ligation of the left anterior descending coronary artery. Significantly lower incidence of left ventricle (LV) free wall rupture was noted between 3rd and 5th day after MI in Hmox1(−/−) mice resulting in their better overall survival. Then, starting from 7th until 21st day post-MI a more potent deterioration of LV function was observed in Hmox1(−/−) than in the surviving Hmox1(+/+) mice. This was accompanied by higher numbers of Ly6C(hi) monocytes in peripheral blood, as well as higher expression of monocyte chemoattractant protein-1 and adhesion molecules in the hearts of MI-operated Hmox1(−/−) mice. Consequently, a greater post-MI monocyte-derived myocardial macrophage infiltration was noted in Hmox1-deficient individuals. Splenectomy decreased the numbers of circulating inflammatory Ly6C(hi) monocytes in blood, reduced the numbers of proinflammatory cardiac macrophages and significantly improved the post-MI LV function in Hmox1(−/−) mice. In conclusion, Hmox1 deficiency has divergent consequences in MI. On the one hand, it improves early post-MI survival by decreasing the occurrence of cardiac rupture. Afterwards, however, the hearts of Hmox1-deficient mice undergo adverse late LV remodeling due to overactive and prolonged post-ischemic inflammatory response. We identified spleen as an important source of these cardiovascular complications in Hmox1(−/−) mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-017-0629-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5440541
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54405412017-06-08 Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice Tomczyk, Mateusz Kraszewska, Izabela Szade, Krzysztof Bukowska-Strakova, Karolina Meloni, Marco Jozkowicz, Alicja Dulak, Jozef Jazwa, Agnieszka Basic Res Cardiol Original Contribution Heme oxygenase-1 (Hmox1) is a stress-inducible protein crucial in heme catabolism. The end products of its enzymatic activity possess anti-oxidative, anti-apoptotic and anti-inflammatory properties. Cardioprotective effects of Hmox1 were demonstrated in experimental models of myocardial infarction (MI). Nevertheless, its importance in timely resolution of post-ischemic inflammation remains incompletely understood. The aim of this study was to determine the role of Hmox1 in the monocyte/macrophage-mediated cardiac remodeling in a mouse model of MI. Hmox1 knockout (Hmox1(−/−)) and wild-type (WT, Hmox1(+/+)) mice were subjected to a permanent ligation of the left anterior descending coronary artery. Significantly lower incidence of left ventricle (LV) free wall rupture was noted between 3rd and 5th day after MI in Hmox1(−/−) mice resulting in their better overall survival. Then, starting from 7th until 21st day post-MI a more potent deterioration of LV function was observed in Hmox1(−/−) than in the surviving Hmox1(+/+) mice. This was accompanied by higher numbers of Ly6C(hi) monocytes in peripheral blood, as well as higher expression of monocyte chemoattractant protein-1 and adhesion molecules in the hearts of MI-operated Hmox1(−/−) mice. Consequently, a greater post-MI monocyte-derived myocardial macrophage infiltration was noted in Hmox1-deficient individuals. Splenectomy decreased the numbers of circulating inflammatory Ly6C(hi) monocytes in blood, reduced the numbers of proinflammatory cardiac macrophages and significantly improved the post-MI LV function in Hmox1(−/−) mice. In conclusion, Hmox1 deficiency has divergent consequences in MI. On the one hand, it improves early post-MI survival by decreasing the occurrence of cardiac rupture. Afterwards, however, the hearts of Hmox1-deficient mice undergo adverse late LV remodeling due to overactive and prolonged post-ischemic inflammatory response. We identified spleen as an important source of these cardiovascular complications in Hmox1(−/−) mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-017-0629-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-05-22 2017 /pmc/articles/PMC5440541/ /pubmed/28534119 http://dx.doi.org/10.1007/s00395-017-0629-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Contribution
Tomczyk, Mateusz
Kraszewska, Izabela
Szade, Krzysztof
Bukowska-Strakova, Karolina
Meloni, Marco
Jozkowicz, Alicja
Dulak, Jozef
Jazwa, Agnieszka
Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice
title Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice
title_full Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice
title_fullStr Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice
title_full_unstemmed Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice
title_short Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice
title_sort splenic ly6c(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440541/
https://www.ncbi.nlm.nih.gov/pubmed/28534119
http://dx.doi.org/10.1007/s00395-017-0629-y
work_keys_str_mv AT tomczykmateusz splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice
AT kraszewskaizabela splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice
AT szadekrzysztof splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice
AT bukowskastrakovakarolina splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice
AT melonimarco splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice
AT jozkowiczalicja splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice
AT dulakjozef splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice
AT jazwaagnieszka splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice